Diagnosis and Management of Psoriasis and Psoriatic Arthritis

Download Report

Transcript Diagnosis and Management of Psoriasis and Psoriatic Arthritis

Diagnosis and Management of
Psoriasis and Psoriatic Arthritis
SIGN November 2010
Objectives

According to this new guideline:
 Be
able to diagnose psoriasis
 Know the recommended treatment in primary
care
 Have an understanding of psoriasis
management in secondary care.
What are the characteristics of
psoriasis?
What risks are associated with
psoriasis or psoriatic arthritis?
Co Morbidities associated with
psoriasis




Diabetes
Hypertension
Hyperlipidaemia
Metabolic syndrome



Obesity
MI – young pt with
severe disease.
Low mood
Treatment - Topical
Short term potent steriod or potent steriod
plus calcipotriol gain improvement in
plaque psoriasis.
 Long term treatment is a Vit D Analogue.
 If unsuccessful then consider dithranol,
coal tar solution or tazaotene gel.

Vitamin D analogues

Calcipotriol and talcalcitol.
 Dovonex,
silkis, curatoderm.
 Dovobet (with betamethasone)
Analogues of vit D and affect cell division
and differentiation
 Do not smell or stain

Coal Tar
Anti-inflammatory properties and antiscaling properties.
 Crude coal tar most effective, but not
tolerated due to smell and mess.
 Contact allergy or folliculits may occur.
 Polytar, alphosyl HC, Cocois

Tazarotene
For plaque psoriasis.
 A retinoid.
 Less effective and more irritation than
calcipotriol.
 Use sparingly on plaques only.
 Clean and odourless.

Dithranol
Effective treatment for plaque psoriasis.
 Irritation and staining of the skin.
 Only on plaques.
 Not in flexures or on the face.



Wear gloves to apply and wash afterwards.
Best used by specialist nursing staff.
Topical therapy
Therapy Efficacy
Remission Maintanence Patient
Coal tar
X
-
-
Steriods XXXX
XXX
X
XX
Dithranol XX
XX
-
-
Tazarotene
XX
XX
XX
XXX
XXX
XX
X
XX
Vit D
XXX
analogues
acceptability
Special Sites
Scalp – scalp preparations – salicylic acid
/ tar preparations. Vit D analogues and
steriods
 Face and Flexures – more easily irritated.

 Moderate
steriods short term
 Vit D Analogues or tacrolimus ointment.
Assessing Psoriasis
 PASI


- calculated based on
severity, intensity,
and surface area
Requires experience
at calculating the
score.
 DLQI

Simple 10 questions,
assess effect on life.
Dermatology Life Quality Index
0-1 = no effect at all on patient's life
2-5 = small effect on patient's life
6-10 = moderate effect on patient's life
11-20 = very large effect on patient's life
21-30 = extremely large effect on patient's
life
Referral to dermatology
Diagnostic problem
 Extensive disease
 Occupational disability / time lost
 Difficult places
 Failure of topical therapy
 Adverse reaction to topical
 DLQI above 6

Generalised Pustular Psoriasis



Life threatening
complications.
May have
erythroderma.
Requires
hospitalisation.
Secondary Care
Erythroderma or generalised pustular
psoriasis need emergency referral to
dermatology.
 These patients should have inpatient care.

Secondary Care - Phototherapy
Narrow band UVB phototherapy should
be offered if failure to topical therapy.
 Three times weekly where practical

Systemic
In general poor studies to go on and of
short duration. However,
 Severe or refractory psoriasis pt should be
offered tx with ciclosporin, methrotrexate,
acitretin.
 If respond – shared care with primary
care.

Biological
Strong evidence base for infliximab (NNT
2) adalimumab, and etanercept (NNT 4).
 Should be offered to pt who do not
respond to systemic therapies.
